Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation
Non-hematopoietic lymph node stromal cells shape immunity by inducing MHC-I-dependent deletion of self-reactive CD8 T cells and MHC-II-dependent anergy of CD4 T cells. In this study, we show that MHC-II expression on lymph node stromal cells is additionally required for homeostatic maintenance of re...
Saved in:
Published in | eLife Vol. 3 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
eLife Sciences Publications Ltd
19.11.2014
eLife Sciences Publications, Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Non-hematopoietic lymph node stromal cells shape immunity by inducing MHC-I-dependent deletion of self-reactive CD8
T cells and MHC-II-dependent anergy of CD4
T cells. In this study, we show that MHC-II expression on lymph node stromal cells is additionally required for homeostatic maintenance of regulatory T cells (Tregs) and maintenance of immune quiescence. In the absence of MHC-II expression in lymph node transplants, i.e. on lymph node stromal cells, CD4
as well as CD8
T cells became activated, ultimately resulting in transplant rejection. MHC-II self-antigen presentation by lymph node stromal cells allowed the non-proliferative maintenance of antigen-specific Tregs and constrained antigen-specific immunity. Altogether, our results reveal a novel mechanism by which lymph node stromal cells regulate peripheral immunity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. Infectious Diseases and Vaccines Therapeutic Area, Janssen Pharmaceutical Companies of Johnson and Johnson, Leiden, Netherlands. |
ISSN: | 2050-084X 2050-084X |
DOI: | 10.7554/elife.04433 |